SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-16-506929
Filing Date
2016-03-16
Accepted
2016-03-16 17:20:01
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 d138808ds3.htm S-3 374268
2 EX-1.1 d138808dex11.htm EX-1.1 182357
3 EX-4.6 d138808dex46.htm EX-4.6 450122
4 EX-5.1 d138808dex51.htm EX-5.1 25078
5 EX-12.1 d138808dex121.htm EX-12.1 16743
6 EX-23.1 d138808dex231.htm EX-23.1 1594
7 GRAPHIC g138808g0309113300318.jpg GRAPHIC 2529
8 GRAPHIC g138808g0309113300646.jpg GRAPHIC 2764
9 GRAPHIC g138808g82b25.jpg GRAPHIC 5793
10 GRAPHIC g138808g89x82.jpg GRAPHIC 6652
11 GRAPHIC g138808g90i97.jpg GRAPHIC 6448
  Complete submission text file 0001193125-16-506929.txt   1084954
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-210248 | Film No.: 161510531
SIC: 2834 Pharmaceutical Preparations